Policy & Regulation
29 October 2020 - - US-based pharmaceutical company Moleculin Biotech, Inc., (NASDAQ: MBRX) has entered into an agreement with the University of Campinas in São Paulo, Brazil to furth...
29 October 2020 - - The New England Journal of Medicine has published data from the monotherapy arms of BLAZE-1, a Phase 2 study assessing the efficacy and safety of US-based pharmaceutical ...
29 October 2020 - - US-based biotechnology company Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has released positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 ou...
29 October 2020 - - A COVID-19 immune response study has revealed new findings that suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective, th...
29 October 2020 - - US-based biotechnology company Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has received written feedback to its Type B Pre-IND (Pre-Investigational New Drug application) meetin...
29 October 2020 - - The US Food and Drug Administration has issued Emergency Use Authorization to allow sample pooling with PerkinElmer New Coronavirus Nucleic Acid Detection Kit to inc...